Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Stem Cell Discovery Engine: an integrated repository and analysis system for cancer stem cell comparisons.
Ho Sui SJ, Begley K, Reilly D, Chapman B, McGovern R, Rocca-Sera P, Maguire E, Altschuler GM, Hansen TA, Sompallae R, Krivtsov A, Shivdasani RA, Armstrong SA, Culhane AC, Correll M, Sansone SA, Hofmann O, Hide W. Ho Sui SJ, et al. Among authors: sompallae r. Nucleic Acids Res. 2012 Jan;40(Database issue):D984-91. doi: 10.1093/nar/gkr1051. Epub 2011 Nov 24. Nucleic Acids Res. 2012. PMID: 22121217 Free PMC article.
Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome.
Gu C, Holman C, Sompallae R, Jing X, Tomasson M, Hose D, Seckinger A, Zhan F, Tricot G, Goldschmidt H, Yang Y, Janz S. Gu C, et al. Among authors: sompallae r. Blood Cancer J. 2018 Feb 15;8(2):22. doi: 10.1038/s41408-018-0060-0. Blood Cancer J. 2018. PMID: 29449574 Free PMC article. No abstract available.
FOXM1 is a therapeutic target for high-risk multiple myeloma.
Gu C, Yang Y, Sompallae R, Xu H, Tompkins VS, Holman C, Hose D, Goldschmidt H, Tricot G, Zhan F, Janz S. Gu C, et al. Among authors: sompallae r. Leukemia. 2016 Apr;30(4):873-82. doi: 10.1038/leu.2015.334. Epub 2015 Dec 9. Leukemia. 2016. PMID: 26648534 Free PMC article.
(18)F-FDG-PET/CT imaging in an IL-6- and MYC-driven mouse model of human multiple myeloma affords objective evaluation of plasma cell tumor progression and therapeutic response to the proteasome inhibitor ixazomib.
Duncan K, Rosean TR, Tompkins VS, Olivier A, Sompallae R, Zhan F, Tricot G, Acevedo MR, Ponto LL, Walsh SA, Tygrett LT, Berger AJ, Waldschmidt T, Morse HC 3rd, Sunderland JJ, Janz S. Duncan K, et al. Among authors: sompallae r. Blood Cancer J. 2013 Nov 29;3(11):e165. doi: 10.1038/bcj.2013.61. Blood Cancer J. 2013. PMID: 24292417 Free PMC article.
45 results